Takafumi Watanebe

A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)

N. Yaegashi, T. Ohta, S. Nagase, 2017, Cancer Chemotherapy and Pharmacology.